Atlas Trials

A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease

Clinical trial NCT02323334 · COMPLETED

Trial details

NCT number
NCT02323334
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteersAlzheimer Disease
Start date
2014-12-01
Primary completion
2016-02-01
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.